Sumanta (Monty) Kumar Pal, M.D., is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Dr. Pal entered college at the age of 13 and began medical school at University of California Los Angeles at the age of 17. After completing his residency training at UCLA, Dr. Pal completed a fellowship program in medical oncology at City of Hope's comprehensive cancer center where he has remained on faculty since 2009.
Over that span of time, he has published more than 350 PubMed cited articles that have been featured in prominent journals including Cancer Discovery, The Journal of Clinical Oncology, The Lancet, Cancer Cell and European Urology.
Dr. Pal holds patents for new drugs currently under development in prostate cancer and also maintains one of the largest portfolios of clinical trials for kidney and bladder cancer research on the West Coast. He developed an integrated program that focuses heavily on collaborations with basic science researchers at the Beckman Research Institute of City of Hope and urologists in the Department of Surgery. Ultimately, Dr. Pal’s goal is to stimulate collaborative research across multiple departments in order to discover novel therapeutic approaches for currently incurable diseases. He has also worked to push the boundaries of personalized medicine in genitourinary cancers with several seminal publications in rare genitourinary cancers that describe unique therapeutic targets. He is the lead investigator on multiple trials, ranging from early phase 1 experiences to late stage phase 3 studies.
Dr. Pal sits on the editorial board for Kidney Cancer and is a reviewer for multiple journals including The Lancet, The Journal of Clinical Oncology, The Journal of Urology, European Urology, New England Journal of Medicine and many others. Dr. Pal has received grants from the National Institute of Health, the Comprehensive Cancer Network, SWOG Cancer Research Network and multiple other leading entities in support of his formidable research.
2009 - present, American Board of Internal Medicine, Medical Oncology
2006 - 2016, American Board of Internal Medicine
2003, M.D., David Geffen School of Medicine at UCLA, Los Angeles, CA
1998, Magna Cum Laude, B.Sc., California State University Los Angeles Early Entrance Program, College in lieu of high school (program initiated at age 13)
2006-2009, Fellowship in Hematology/Oncology, City of Hope/Harbor-UCLA Medical Center, Los Angeles, CA
2004-2006, Internal Medicine, UCLA Medical Center, Los Angeles, CA
2003-2004, Internal Medicine, UCLA Medical Center, Los Angeles, CA
2020-present, Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2009-present, Co-director, Kidney Cancer Program, City of Hope, Duarte, CA
2016-2020, Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2009-2016, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Awards & Memberships
2021, Fellow of the American Society of Clinical Oncology (FASCO)
2020, 40 Under 40 in Cancer
2020, Los Angeles Business Journal, Top Doctor
2020, City of Hope, Clinical Teaching Award
2018, City of Hope Mentor of the Year Award
2018-present, Trials Consortium (SUO-CTC)
2017-2019, Cancer Communications Committee, Chair
2016-present, Leadership Development Program
2015-present, Social Media Working Group
2013-present, Genitourinary Cancers Committee
2012-2013, HER2-Positive Breast Cancer Committee
2010-present, National Comprehensive Cancer Network Bladder Cancer Committee
2015-present, Kidney Cancer Association Scientific Program Committee, Chair
2015-present, Society of Immunotherapy for Cancer Patient Meeting, Chair
2015-present, Society of Urologic Oncology Prostate Cancer Committee, Chair
2006-present, American Society of Clinical Oncology
To view all publications by Sumanta Kumar Pal, please visit this link here.
Ratings & Reviews
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Know important info medical history
Rate provider 0-10
Recommend this provider office
Provider listen carefully to you
Show respect for what you say
Spend enough time with you
Provider explain in way you understand
Dr. Pal has my complete confidence. I can't imagine any other doctor that is more qualified. Furthermore, he treats me as if I am his most important patient. He is excellent in so many ways. - Verified patient
I have recommended COH to others. They have had fabulous results with their diagnosis and treatment! Thank you. - Verified patient
provider very good - Verified patient
Although he won't be the physician who will be attending to my care, later, our initial consultation with him and his assurance that I will be in great care with the specialists he referred me to gave me a lot of confidence and trust to City of hope. - Verified patient
Dr Pal is exceptional, accessible and reassuring - Verified patient